Literature DB >> 11237376

Morphine and alternative opioids in cancer pain: the EAPC recommendations.

G W Hanks1, F Conno, N Cherny, M Hanna, E Kalso, H J McQuay, S Mercadante, J Meynadier, P Poulain, C Ripamonti, L Radbruch, J R Casas, J Sawe, R G Twycross, V Ventafridda.   

Abstract

An expert working group of the European Association for Palliative Care has revised and updated its guidelines on the use of morphine in the management of cancer pain. The revised recommendations presented here give guidance on the use of morphine and the alternative strong opioid analgesics which have been introduced in many parts of the world in recent years. Practical strategies for dealing with difficult situations are described presenting a consensus view where supporting evidence is lacking. The strength of the evidence on which each recommendation is based is indicated. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237376      PMCID: PMC2363790          DOI: 10.1054/bjoc.2001.1680

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain.

Authors:  D E Moulin; J H Kreeft; N Murray-Parsons; A I Bouquillon
Journal:  Lancet       Date:  1991-02-23       Impact factor: 79.321

Review 2.  Opioid-responsive and opioid-non-responsive pain in cancer.

Authors:  G W Hanks
Journal:  Br Med Bull       Date:  1991-07       Impact factor: 4.291

3.  The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.

Authors:  P J Hoskin; G W Hanks; G W Aherne; D Chapman; P Littleton; J Filshie
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of morphine.

Authors:  P A Glare; T D Walsh
Journal:  Ther Drug Monit       Date:  1991-01       Impact factor: 3.681

5.  Driving ability in cancer patients receiving long-term morphine analgesia.

Authors:  A Vainio; J Ollila; E Matikainen; P Rosenberg; E Kalso
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

6.  Breakthrough pain: definition, prevalence and characteristics.

Authors:  Russell K Portenoy; Neil A Hagen
Journal:  Pain       Date:  1990-06       Impact factor: 6.961

Review 7.  Rectal, buccal, and sublingual narcotics for the management of cancer pain.

Authors:  C Ripamonti; E Bruera
Journal:  J Palliat Care       Date:  1991       Impact factor: 2.250

8.  Morphine and oxycodone hydrochloride in the management of cancer pain.

Authors:  E Kalso; A Vainio
Journal:  Clin Pharmacol Ther       Date:  1990-05       Impact factor: 6.875

9.  Transdermal fentanyl: clinical pharmacology.

Authors:  K A Lehmann; D Zech
Journal:  J Pain Symptom Manage       Date:  1992-04       Impact factor: 3.612

10.  Opioid rotation for toxicity reduction in terminal cancer patients.

Authors:  N D de Stoutz; E Bruera; M Suarez-Almazor
Journal:  J Pain Symptom Manage       Date:  1995-07       Impact factor: 3.612

View more
  186 in total

1.  [Palliative care: care in the final days].

Authors:  M A Benítez del Rosario; L Pascual; A Asensio Fraile
Journal:  Aten Primaria       Date:  2002-09-30       Impact factor: 1.137

2.  The importance of clinical practice guidelines (CPGs) for the quality and development of supportive care in Central and Eastern European (CEE) countries.

Authors:  Snezana Bosnjak
Journal:  Support Care Cancer       Date:  2003-10-15       Impact factor: 3.603

3.  [Evolution of opiate consumption in a Madrid area between 1997 and 2001].

Authors:  A Alonso Babarro; M Varela Cerdeira; G Aparicio Jabalquinto
Journal:  Aten Primaria       Date:  2003-10-15       Impact factor: 1.137

4.  "I am in pain!"-a case report of illicit use of transdermal fentanyl patches.

Authors:  Wei Guan; Ronald Schneider; James Patterson
Journal:  Prim Care Companion CNS Disord       Date:  2011

5.  Dying of hematologic patients--treatment characteristics in a German University Hospital.

Authors:  Patrick Brück; Malgorzata Pierzchlewska; Marta Kaluzna-Oleksy; Maria Elizabeth Ramos Lopez; Mathias Rummel; Dieter Hoelzer; Angelika Böhme
Journal:  Support Care Cancer       Date:  2012-03-13       Impact factor: 3.603

6.  Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database.

Authors:  Lars Morten Skollerud; Olav Ms Fredheim; Kristian Svendsen; Svetlana Skurtveit; Petter C Borchgrevink
Journal:  Support Care Cancer       Date:  2012-06-01       Impact factor: 3.603

7.  [To sedate or not to sedate-that is the question here : Palliative sedation between standard care and flexibility].

Authors:  L Radbruch; F Nauck
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

Review 8.  Management of cancer pain.

Authors:  Sebastiano Mercadante
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

Review 9.  Road map for pain management in pancreatic cancer: A review.

Authors:  Marie José Lahoud; Hampig Raphael Kourie; Joelle Antoun; Lana El Osta; Marwan Ghosn
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

Review 10.  Breakthrough pain in elderly patients with cancer: treatment options.

Authors:  Sophie Pautex; Nicole Vogt-Ferrier; Gilbert B Zulian
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.